Stock Track | GE Healthcare Pre-market Soars 5.76% as Q2 Earnings Beat and Full-Year Guidance Reaffirmed

Stock Track

Jul 29

GE Healthcare Technologies Inc (GEHC) stock surged 5.76% in pre-market trading on Wednesday, driven by stronger-than-expected second-quarter results and a reaffirmed full-year outlook.

The company reported Q2 revenue of $5.3 billion, surpassing the IBES estimate of $5.264 billion, while adjusted earnings per share reached $1.13, well above the $1.04 consensus. Net income for the quarter was $561 million, with EPS of $1.24. The robust performance signals healthy demand across its imaging, ultrasound, and patient care segments.

Investors also welcomed the reaffirmation of 2026 guidance, with adjusted EPS projected between $4.80 and $5.00, aligning with the FactSet estimate of $4.88. This vote of confidence carries added weight after the company had trimmed its forecast in April due to cost headwinds, making the steady outlook a positive catalyst for the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1144014253"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144014253\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144014253?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-29 18:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144014253","market":"sg","top_or_hot":-1,"title":"Stock Track | GE Healthcare Pre-market Soars 5.76% as Q2 Earnings Beat and Full-Year Guidance Reaffirmed","media":"Stock Track","content":"<p>GE Healthcare Technologies Inc (GEHC) stock surged 5.76% in pre-market trading on Wednesday, driven by stronger-than-expected second-quarter results and a reaffirmed full-year outlook.</p>\n        <p>The company reported Q2 revenue of $5.3 billion, surpassing the IBES estimate of $5.264 billion, while adjusted earnings per share reached $1.13, well above the $1.04 consensus. Net income for the quarter was $561 million, with EPS of $1.24. The robust performance signals healthy demand across its imaging, ultrasound, and patient care segments.</p>\n        <p>Investors also welcomed the reaffirmation of 2026 guidance, with adjusted EPS projected between $4.80 and $5.00, aligning with the FactSet estimate of $4.88. This vote of confidence carries added weight after the company had trimmed its forecast in April due to cost headwinds, making the steady outlook a positive catalyst for the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | GE Healthcare Pre-market Soars 5.76% as Q2 Earnings Beat and Full-Year Guidance Reaffirmed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | GE Healthcare Pre-market Soars 5.76% as Q2 Earnings Beat and Full-Year Guidance Reaffirmed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-29 18:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GE Healthcare Technologies Inc (GEHC) stock surged 5.76% in pre-market trading on Wednesday, driven by stronger-than-expected second-quarter results and a reaffirmed full-year outlook.</p>\n        <p>The company reported Q2 revenue of $5.3 billion, surpassing the IBES estimate of $5.264 billion, while adjusted earnings per share reached $1.13, well above the $1.04 consensus. Net income for the quarter was $561 million, with EPS of $1.24. The robust performance signals healthy demand across its imaging, ultrasound, and patient care segments.</p>\n        <p>Investors also welcomed the reaffirmation of 2026 guidance, with adjusted EPS projected between $4.80 and $5.00, aligning with the FactSet estimate of $4.88. This vote of confidence carries added weight after the company had trimmed its forecast in April due to cost headwinds, making the steady outlook a positive catalyst for the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GEHC","symbol_name":"GE HEALTHCARE TECHNOLOGIES INC","start_time":0,"source_url":"","article_id":"1144014253","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144014253","pubTimestamp":1785321163,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"GE Healthcare Technologies Inc (GEHC) stock surged 5.76% in pre-market trading on Wednesday, driven by stronger-than-expected second-quarter results and a reaffirmed full-year outlook.         The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GEHC":"GE HEALTHCARE TECHNOLOGIES INC"},"translate_title":"股票跟踪 | GE 医疗保健第二季度盈利超出预期并重申全年指引，盘前股价飙升 5.76%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GEHC":1},"content_text":"GE Healthcare Technologies Inc (GEHC) stock surged 5.76% in pre-market trading on Wednesday, driven by stronger-than-expected second-quarter results and a reaffirmed full-year outlook.\nThe company reported Q2 revenue of $5.3 billion, surpassing the IBES estimate of $5.264 billion, while adjusted earnings per share reached $1.13, well above the $1.04 consensus. Net income for the quarter was $561 million, with EPS of $1.24. The robust performance signals healthy demand across its imaging, ultrasound, and patient care segments.\nInvestors also welcomed the reaffirmation of 2026 guidance, with adjusted EPS projected between $4.80 and $5.00, aligning with the FactSet estimate of $4.88. This vote of confidence carries added weight after the company had trimmed its forecast in April due to cost headwinds, making the steady outlook a positive catalyst for the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}